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Abstract
Introduction: To study the use of pain medications for persistent index knee pain and their predictors after
primary Total Knee Arthroplasty (TKA).
Methods: The Mayo Total Joint Registry collects patient-reported data including pain medication use on all
patients who undergo TKA. We used data from patients who underwent primary TKA from 1993-2005. We
examined whether gender, age (reference, ≤60 yrs), body mass index (BMI; reference, <25 kg/m2), comorbidities
measured by Deyo-Charlson index (5-point increase), anxiety and depression predicted use of pain medications
(non-steroidal anti-inflammatory drugs (NSAIDs) and opioids) 2- and 5-years after primary TKA. Multivariable logistic
regression additionally adjusted for operative diagnosis, American Society of Anesthesiologists (ASA) score, implant
fixation and distance from the medical center.
Results: 7,139 of the 10,957 eligible (65%) at 2-years and 4,234 of 7,404 eligible (57%) completed questionnaires.
Significant predictors of NSAIDs use were (Odds ratio (95% confidence interval)): male gender at 2- and 5-years,
0.5 (0.4, 0.6) and 0.6 (0.5, 0.8); age >70-80 years, 0.7 (0.5, 0.9), 0.6 (0.4, 0.8); and depression, 1.4 (1.0, 1.8) and 1.7 (1.1, 2.5).
BMI ≥40 was associated with NSAIDs use only at 2-years, 1.6 (1.1, 2.5). Significant predictors of opioid pain medication
use at 2- and 5-years were: male gender, 0.5 (0.3, 0.9) and 0.4 (0.2, 0.8); age >70-80 years, 0.3 (0.1, 0.6), 0.3 (0.1, 0.8); and
anxiety, 3.0 (1.6, 5.7) and 4.0 (1.7, 9.4).
Conclusions: Female gender and younger age were associated with higher risk of use of NSAIDs and opioids after
primary TKA. Depression was associated with higher NSAID use and anxiety with higher opioid pain medication
use after primary TKA.
Introduction
Primary total knee arthroplasty (TKA) is an extremely suc-
cessful operation associated with significant pain relief and
improvement in function and quality of life [1]. The
majority of patients report significant improvement in
knee pain severity after primary TKA, with only 7% of
patients reporting moderate-severe index knee pain 2
years after primary TKA [2]. Studies showed a reduction
in the use of oral anti-inflammatory [3] and opioid pain
medications [4] after TKA. This evidence supports a sig-
nificant reduction in the use of pain medications after
TKA.
While most patients have significant improvement in
knee pain after TKA, some patients continue using pain
medications for the treatment of index knee pain. Con-
tinued use of pain medications post-operatively for the
index joint is a surrogate for less beneficial outcomes
after arthroplasty. Use of pain medication may be asso-
ciated with significant adverse events, especially in the
elderly [5-7]. Limited data exist on the factors that pre-
dict the use of pain medication after TKA. In a UK study,
higher body mass index (BMI) was associated with use of
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anti-inflammatory drugs after TKA [3]. Higher BMI and
younger age were found to be associated with the use of
opioid pain medications 12 months after TKA [4]. While
these studies provide insights into predictors of the use
of opioid pain medication and non-steroidal anti-inflam-
matory drugs (NSAIDs), the analysis was not adjusted for
any confounders, making the results potentially biased.
Studies in other patient populations have reported that
depression, anxiety and medical comorbidities may be
associated with chronic use of pain medications [8,9]. In
our recent analyses that were adjusted for multiple con-
founders, we found that female gender, depression and
higher body mass index (BMI) were associated with the
use of NSAIDs and opioid pain medications after total
hip arthroplasty (THA) [10]. Whether this is true for
patients undergoing TKA is not known.
We hypothesized that patient demographics and
comorbidities will be associated with the use of pain
medications after TKA. Specifically, we assessed whether
female gender, younger age, higher BMI, pre-operative
medical comorbidities, depression and anxiety, were
associated with use of NSAIDs and opioid pain medica-
tions at 2 and 5 years after TKA. We describe the meth-
ods and results as recommended in the Strengthening of




For this study, we used the data collected prospectively in
the Mayo Total Joint Registry, one of the largest US joint
registries, as detailed in previous studies [12,13]. This clini-
cal registry captures data on every patient undergoing
arthroplasty (knee, hip, shoulder and others) at Mayo
Clinic, Rochester, Minnesota, and follows them prospec-
tively. Thus, the study design was an observational cohort
study. Starting in 1993, patient-reported outcomes (PROs)
including pain and function data reported on a validated
knee questionnaire [14], were captured electronically.
Patients were eligible if they had undergone primary TKA
at the Mayo clinic between 1993 and 2005. We used 2-
and 5-year follow-up data from these patients. The time
period 1993 to 2005 was chosen because data of interest
have been captured electronically since 1993, and the time
frame allowed capture of follow-up data. Several previous
studies have reported data on pain and function from this
registry [2,15-17]. The validated knee questionnaire was
administered at 2 and 5 years postoperatively by mail or in
person at the clinical follow-up visit. Patients who did not
return the mailed survey and failed to return for follow-up
clinic visits, had the knee questionnaire administered on
the telephone by dedicated Joint Registry staff. The Institu-
tional Review Board at the Mayo Clinic, Rochester,
approved the study.
Outcomes of interest
The outcomes of interest were the use of pain medications
for index TKA pain at 2- and 5-years post-primary TKA.
Use of NSAIDs and opioid pain medications was assessed
separately, since risk factors for their continued use after
primary TKA may differ. Patients were asked the following
question, ‘Do you use any of the following medications for
the pain in your operated knee?’, and were asked to select
one of the following responses: ‘none’, ‘non-steroidal anti-
inflammatory drugs (NSAIDs)’, ‘narcotics’, or ‘oral ster-
oids’. We used none/oral steroid as the reference category
and use of opioids and use of NSAIDs separately as
outcomes.
Predictors of interest
These included important patient characteristics, includ-
ing age and gender (unmodifiable), and clinical factors,
including BMI, medical comorbidities, depression and
anxiety (modifiable). Age was categorized, as previously
[2,18] into ≤ 60, 61 to 70, 71 to 80 and > 80 years. BMI
was categorized, as previously [19] into ≤ 25, 25.1 to 29.9,
30 to 34.9, 35 to 39.9 and ≥ 40 kg/m2. We used the
Deyo-Charlson score, a validated comorbidity measure
[20]; this was treated as a continuous variable, and we
assessed the association of a 5-point increase with out-
comes. This is the most commonly used comorbidity
measure consisting of a weighted scale of 19 comorbid-
ities (including cardiac, pulmonary, renal, hepatic disease,
diabetes, cancer, HIV etcetera), expressed as a summative
score [21,22]. Depression and anxiety were assessed by
the presence or absence before the TKA, of International
Classification of Diseases, ninth revision (ICD-9) codes
for depression and anxiety. ICD-9 codes were obtained
from patient’s entire medical record, including, but not
limited to, notes from the orthopedic surgeon, anesthe-
siologist and other health care providers.
Data sources
Data on the dates of the TKA, demographic details (age,
gender, BMI), operative diagnosis, implant fixation, dis-
tance from the medical center and American Society of
Anesthesiologists (ASA) class were obtained from the
Mayo Total Joint Registry, since they are captured for
every patient. ICD-9 codes for the Deyo-Charlson comor-
bidities, anxiety and depression were obtained the Mayo
Clinic electronic databases. Median household income was
calculated using the zip code data from the Mayo Total
Joint Registry and the census data for median income for
the respective year of surgery.
Bias
We tried to minimize confounding bias by including fac-
tors either previously known, or suspected to be asso-
ciated with use of pain medication after arthroplasty, but
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recognize that residual confounding is a limitation of
study design. We examined for collinearity of variables in
the analyses. We used generalized estimating equations
(GEE) to account for correlation of observations (due to
bilateral TKA in patients, performed simultaneously or
sequentially) in our dataset. We anticipated non-response
to be higher at 5 than 2 years, and acknowledge this as a
study limitation.
Sample size
No formal sample size calculations were done. We wanted
a large enough sample to study the use of NSAIDs and
opioid pain medications without having too long a study
period, therefore chose all eligible patients from 1993
to 2005.
Statistical analyses
Baseline clinical and demographic characteristics were
compared using Student’s t-test for continuous data and
the chi-square test for categorical measures. Responder
and non-responder characteristics were compared using
logistic regression analyses. Missing data were treated as
missing, and not imputed.
Multivariable adjusted logistic regression analyses were
performed for NSAIDS use and opioid pain medication
use at 2 and 5 years after primary TKA. For these analyses,
we used a GEE approach to adjust for the correlation
between observations on the same subject due to replace-
ment of both knees. In addition to adjusting for primary
predictors of interest, including age, gender, BMI, medical
comorbidities, anxiety and depression, all logistic regres-
sion analyses were also adjusted for the following potential
confounders: (1) operative diagnosis; (2) cemented, unce-
mented, or hybrid implant fixation; (3) ASA class [23] I or
II vs. III or IV; (4) median household income level
(≤ $35K, > $35 to $45K, > $45K) determined using the zip
code and the median household income for geographical
area using the census data for the respective year of the
survey, as performed previously [17]; and (4) distance
from the medical center of <100, 100 to 500 and > 500
miles/overseas. Distance from the medical center was
included because the Mayo Clinic provides TKA to local
residents, and also a serves as a referral center for patients
traveling from afar; these patients may have different dis-
ease severity and expectations, which may impact pain
outcomes and the use of pain medication.
We calculated Spearman’s coefficient for correlation
between key variables suspected to have collinearity, as fol-
lows: ASA class and Deyo-Charlson score, 0.22; ASA class
and age, 0.19; age and Deyo-Charlson score, 0.14. Thus, all
clinically important variables were included in the multi-
variable-adjusted analyses. All variables included in models
were those based on clinical importance, rather than sta-
tistical significance. Goodness of fit was calculated by
quasi likelihood function, a low value indicating a better
fit. Odds ratios and 95% confidence intervals are pre-
sented. A P-value < 0.05 and 95% confidence intervals not
including unity was taken to indicate statistical signifi-
cance. Since the results of univariate and multivariable-
adjusted analyses were similar, we present both types of
analyses, but focus mainly on multivariable-adjusted
estimates.
Results
Characteristics of the study population and the non-
responders
Of the 11,294 patients who underwent primary TKA,
10,957 were alive at 2-year follow-up; of these, 7,139 (65%)
completed the 2-year questionnaire (Figure 1); 7,404 of
the patients were alive and eligible for 5-year follow-up,
and 4,234 (57%) completed the 5-year questionnaire.
Primary TKA patients responding to the questionnaire
had a mean age of 68 years; 87% were overweight or obese
(BMI ≥ 25), and 55 to 56% were female (Table 1). Osteoar-
thritis was the commonest underlying diagnosis and
majority of the implants were cemented. Non-responders
were more likely to be younger, have diagnosis other than
osteoarthritis, have higher ASA class (III or IV), higher
Deyo-Charlson comorbidity index score, and live > 500
miles from the Mayo Clinic (Additional file 1).
Prevalence of use of pain medications after TKA
Use of NSAIDs for index TKA pain was reported by 8.5%
of patients (610/7139) at 2-year and 9% (381/4234) at
5-year follow-up. Use of opioid medication for index
TKA pain was reported by 1.4% of patients (103/7139) at
2 years and 1.4% (61/4234) at 5 years.
Predictors of use of NSAIDs 2 and 5 years after primary
TKA
Univariate associations are shown in Table 2. In multi-
variable-adjusted analyses, at 2 years after primary TKA,
significantly lower odds of NSAIDs use was noted in
men with odds of 0.5, compared to women (Table 3).
Compared to patients 60 years and younger, those aged
71 to 80 and > 80 years had significantly lower odds of
NSAID use at 2 years after primary TKA (Table 3). Com-
pared to patients with BMI < 25 kg/m2, those with BMI
≥ 40 had significantly higher odds of NSAID use 2 years
after primary TKA. Presence of depression increased the
odds of NSAID use by 1.4, compared to those without
depression. The Deyo-Charlson comorbidity index and
anxiety were not significantly associated with NSAID use.
At 5 years after primary TKA, male gender and ages 61
to 70 and 71 to 80 years (compared to age 60 and lower)
were associated with significantly lower odds of NSAID
use, while depression was associated with significantly
higher odds of NSAID use (Table 3). BMI, Deyo-Charlson
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comorbidity index and anxiety were not significantly asso-
ciated with greater NSAID use. Sensitivity analyses that
additionally adjusted these models for preoperative pain
and functional limitation led to no change in the signifi-
cance, and minimal change in the strength of association
of these variables (gender, age, depression) at 2 and
5 years.
Predictors of use of opioid pain medications 2 and 5
years after primary TKA
Univariate associations are shown in Table 4. In multivari-
able-adjusted analyses, at 2 years, men had odds of 0.5
of opioid pain medication use, and patients aged 71 to
80 years had odds of 0.3 (compared to those age 60 years
or lower) for using opioid pain medication (Table 5).
Anxiety was associated with 3.1 times odds of use of
opioid pain medications 2 years after primary TKA. At 5
years after primary TKA, male gender and age 71 to 80
years were associated with lower risk, and anxiety was
associated with increased risk of the use of the opioid pain
medication.
Discussion
In this study, we found that younger age and depression
were associated with higher odds of use of NSAIDs, and
male gender with lower odds of use of NSAIDs for the
variables in multivariable models
Cases excluded due missing
Survey non
All primary TKA patients 1993-2005 
 N= 11,294  
Potentially eligible  
10,957 were alive at 2-year follow-up 
7,404 were alive and eligible for 5-year 
Survey responders: 
7,139 (65%) completed a 2-year questionnaire 
4,234 (57%) completed a 5-year questionnaire 
Died prior to survey 
  at 2-years, n=300 
  at 5-years, n=810 
Not eligible due to follow-up  
  <2-years, n=37 
  <5-years, n=3,080 
-responders  
3,818 (35%) at 2-years 
3,170 (43%) at 5-years 
 
 
Cases included in multivariable models  
NSAIDs 2-year: 6,108 (86%) 
NSAIDs 5-year: 3,487 (82%) 
Narcotics 2-year: 6,108 (86%) 
Narcotics 5-year: 3,487 (82%) 
2-year: 1,031 (14%) 
5-year: 747 (18%) 
Figure 1 Study cohort flow chart. TKA, total knee arthroplasty; NSAID, non-steroidal anti-inflammatory drug.
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treatment of index TKA pain, 2 and 5 years after pri-
mary TKA. BMI ≥ 40 was associated with higher
NSAID use 2 years after primary TKA. Female gender,
younger age and anxiety were associated with higher
odds of use of opioid pain medication for the treatment
of index TKA pain at both 2 and 5 years after primary
TKA.
Our study has many novel findings that add to the cur-
rent knowledge. The prevalence of use of pain medication
at 2-year (8.5% NSAIDs and 1.4% opioids), or 5-year
(9% NSAIDs and 1.4% opioids) follow-up after primary
TKA in our study is similar to that reported previously in
a cohort of primary THA patients from our clinical regis-
try at the same time-points (12 to 13% NSAIDs or 2 to
Table 1 Characteristics of patients with primary total knee arthroplasty
Two-year follow-up(n = 7,139) Five-year follow-up(n = 4,234)
Mean age, yrs (± SD) 68 ± 10 68 ± 10
Men/women (%) 44/56 45/55
Bilateral (%) 20 23
Age groups (%)
≤ 60 yrs 18 18
> 60 to 70 yrs 35 37
> 70 to 80 yrs 38 38
> 80 yrs 8 7
Body mass index, kg/m2 (%)
< 25.0 13 13
25.0 to 29.9 35 36
30.0 to 34.9 29 43
35.0 to 39.9 14 7
≥ 40.0 9 7
ASA score (%)
Class I to II 58 58





Rheumatoid arthritis/ othera Inflammatory arthritis conditions 4 4
Osteoarthritis 94 93
Other 2 3
ASA, American Society of Anesthesiologists. aOther includes avascular necrosis, fracture, neoplasms, Paget’s disease, septic arthritis, etcetera.
Table 2 Univariate predictors of use of non-steroidal anti-inflammatory drugs after primary total knee arthroplasty
Univariate analysis, 2-year follow-up Univariate analysis, 5-year follow-up
Odds ratio (95% CI) P-value Odds ratio (95% CI) P-value
Male gender (reference female) 0.51 (0.42, 0.63) < 0.001a 0.66 (0.52, 0.85) 0.001a
Age (reference ≤ 60 yrs)
> 60 to 70 yrs 0.78 (0.62, 0.99) 0.04a 0.59 (0.41, 0.80) 0.001a
> 70 to 80 yrs 0.60 (0.47, 0.76) < 0.001a 0.54 (0.39, 0.73) < 0.001a
> 80 yrs 0.52 (0.35, 0.77) 0.001a 0.95 (0.61, 1.49) 0.84
Body mass index (reference < 25 kg/m2)
25.0 to 29.9 1.15 (0.85, 1.70) 0.30 1.13 (0.77, 1.63) 0.54
30.0 to 34.9 1.17 (0.84, 1.62) 0.35 1.02 (0.72, 1.74) 0.92
35.0 to 39.9 1.67 (1.17, 2.38) 0.005a 0.85 (0.54, 1.36) 0.50
≥ 40.0 2.32 (1.61, 3.35) < 0.001a 1.50 (0.91, 2.48) 0.11
Deyo-Charlson index (5-point change) 1.06 (0.83, 1.36) 0.62 0.88 (0.65, 1.19) 0.40
Depression (reference no depression) 1.93 (1.51, 2.47) < 0.001a 1.85 (1.32, 2.60) < 0.001a
Anxiety (reference no anxiety) 1.58 (1.14, 2.19) 0.006a 1.13 (0.69, 1.85) 0.62
aSignificant odds ratios and P-values; CI, confidence interval.
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3% opioids) [10]. Loss to follow-up and non-response bias
may explain this discrepancy in use of pain medication
after THA vs. TKA, since poorer pain outcomes are
expected after TKA than after THA, based on other clini-
cal outcomes studies of pain. The proportions are lower,
as expected, than the previously reported overall 14% pre-
valent use of opioids 1 year after TKA [4] and 49% for use
of any NSAID 2 years after TKA [3]. The use of pain med-
ication in both these studies represented the overall use of
NSAIDs or opioids compared to use of these medications
for persistent index arthroplasty pain. Our study outcome
captures patients with inadequate relief of index arthro-
plasty pain leading to persistent use of either NSAIDs or
opioid pain medications. This represents a clinically
important outcome for patients undergoing arthroplasty.
Studies are needed to examine use of these medications at
long-term follow-up after TKA.
Preoperative depression predicted use of NSAIDs for
index TKA pain at 2 and 5 years after primary TKA. In an
unadjusted analysis, one previous study reported that
female gender and younger age were associated with
higher use of opioid pain medication in TKA [4]. Our
study confirms this finding in a multivariable-adjusted
analysis, and extends this observation to 2 and 5 years
after primary TKA. Depression predicts pain at 1 year [24]
and pain and function at 2-year [25] and 5-year follow-up
Table 3 Multivariable-adjusted* predictors of use of non-steroidal anti-inflammatory drugs after primary total knee
arthroplasty
Multivariable-adjusted* analysis, 2-year follow-
up
Multivariable-adjusted* analysis, 5-year follow-
up
Odds ratio (95% CI) P-value Odds ratio (95% CI) P-value
Male gender (reference female) 0.52 (0.41, 0.64) < 0.001a 0.64 (0.48, 0.85) 0.002a
Age (reference ≤ 60 yrs)
> 60 to 70 yrs 0.92 (0.70, 1.20) 0.53 0.57 (0.41, 0.80) 0.001a
> 70 to 80 yrs 0.72 (0.54, 0.95) 0.02a 0.56 (0.39, 0.79) 0.001a
> 80 yrs 0.52 (0.33, 0.82) 0.005a 1.00 (0.61, 1.64) 0.99
Body mass index (reference < 25 kg/m2)
25.0 to 29.9 1.20 (0.85, 1.70) 0.30 1.32 (0.87, 2.00) 0.20
30.0 to 34.9 1.08 (0.76, 1.55) 0.66 1.12 (0.72, 1.74) 0.63
35.0 to 39.9 1.44 (0.98, 2.13) 0.07 0.84 (0.50, 1.41) 0.50
≥ 40.0 1.64 (1.08, 2.48) 0.02a 1.22 (0.68, 2.20) 0.50
Deyo-Charlson index (5-point change) 1.06 (0.80, 1.41) 0.68 0.93 (0.67, 1.31) 0.69
Depression (reference no depression) 1.39 (1.04, 1.85) 0.03a 1.68 (1.12, 2.51) 0.01a
Anxiety (reference no anxiety) 1.11 (0.77, 1.61) 0.56 0.85 (0.49, 1.47) 0.56
*Adjusted for American Society of Anesthesiologists (ASA) score, distance from the medical center, income, operative diagnosis and implant fixation in addition
to all the variables in the table. aSignificant odds ratios and P-values; CI, confidence interval. Goodness of fit statistic calculated as quasi likelihood ratio with
lower value indicating a better fit: 2 years, 3461.7; 5 years, 2098.4.
Table 4 Univariate predictors of use of opioid pain medication after primary total knee arthroplasty
Univariate analysis, 2-year follow-up Univariate analysis, 5-year follow-up
Odds ratio (95% CI) P-value Odds ratio (95% CI) P-value
Male gender (reference female) 0.51 (0.42, 0.63) < 0.001a 0.66 (0.52, 0.85) 0.001a
Age (reference ≤ 60 yrs)
> 60 to 70 yrs 0.78 (0.35, 0.77) 0.001a 0.59 (0.43, 0.80) 0.001a
> 70 to 80 yrs 0.60 (0.47, 0.76) < 0.001a 0.54 (0.39, 0.73) < 0.001a
> 80 yrs 0.52 (0.33, 0.82) 0.04a 0.95 (0.61, 1.49) 0.84
Body mass index (reference < 25 kg/m2)
2.0 to 29.9 1.15 (0.84, 1.59) 0.37 1.13 (0.77, 1.63) 0.54
30.0 to 34.9 1.17 (0.84, 1.62) 0.35 1.02 (0.69, 1.51) 0.92
35.0 to 39.9 1.67 (1.17, 2.38) 0.005a 0.85 (0.54, 1.36) 0.50
≥ 40.0 2.32 (1.61, 3.35) < 0.001a 1.50 (0.91, 2.48) 0.11
Deyo-Charlson index (5-point change) 1.06 (0.83, 1.36) 0.62 0.88 (0.65, 1.19) 0.40
Depression (reference no depression) 1.93 (1.51, 2.47) <0.001a 1.85 (1.32, 2.60) <0.001a
Anxiety (reference no anxiety) 1.58 (1.14, 2.19) 0.006a 1.13 (0.69, 1.85) 0.62
aSignificant odds ratios and P-values; CI, confidence interval.
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after primary TKA [26]. To our knowledge, there are no
published studies that have examined whether depression
is associated with use of pain medication 2 to 5 years after
primary TKA. We speculated that depression might be
associated with use of NSAIDs and opioids, but our study
found that depression predicted NSAIDs use and anxiety,
but not depression, predicted opioid use after primary
TKA. These analyses were adjusted for multiple demo-
graphic and clinical factors suggesting that this is an inde-
pendent association. This finding suggests that screening
for depression and anxiety prior to surgery may help iden-
tify patients at-risk for poorer pain outcomes. Further stu-
dies need to examine if preoperative optimization of
depression and anxiety can reduce the use of pain medica-
tions after primary TKA.
The association of male gender with lower likelihood of
use of NSAIDs and opioid pain medication merits some
discussion. Lower odds of use of NSAIDs and opioids in
men vs. women with primary TKA is similar to lower
analgesic use reported for men compared to women in
national cohorts of patients in the US and Sweden
[27,28]; our study extends this finding to populations
undergoing primary TKA.
The association of older age, compared to patients
60 years and younger, with lower odds of use of NSAIDs
and opioids is interesting. Other studies have reported
lower use of pain medication or use of lower doses and/or
greater benefit with the same doses in older individuals
compared to younger controls [29-34]. This may be
related to higher perceived risk of associated adverse
events and contraindications, higher pain thresholds and/
or patient preference for use or non-medical interventions
in the elderly compared to younger patients.
These findings must be interpreted in conjunction with
our previously published findings of pain and function
outcomes in this cohort of patients. Higher Deyo-Charl-
son index, female gender, higher BMI and older age were
associated with worse functional limitation [17], while
female gender, higher comorbidity and younger age, but
not BMI, were associated with worse pain outcomes [35]
after primary TKA. In the current study, we found that
female gender and younger age were associated with
higher odds of use of NSAIDs and opioid pain medica-
tions. The differences in factors associated with each of
the three outcomes, namely the use of pain medication,
moderate-severe pain and moderate-severe functional
limitation, should not be surprising. Conceptually, these
domains have some overlap, but these not the same or
simply surrogates for each other.
Our study has several strengths. We used multivariable
analyses to assess predictors of the use of NSAIDs and
opioid pain medication after primary TKA in a large
sample of patients from a prospective US clinical joint
registry. Most previous studies were limited to 1- to 2-
year follow-up, did not ask about use of medication spe-
cifically for knee pain, and did not control for important
covariates that can impact the use of pain medication
(including depression and anxiety). The use of pain medi-
cation after primary TKA is under-studied in the arthro-
plasty literature.
Our study has several limitations. Non-response and
referral bias may limit generalizability to general popula-
tions. The response rate of 65% at 2 years and 56% at
5 years, is similar to the average response rate of 60% in
large surveys of this size [36]. Despite controlling for sev-
eral important confounders and covariates, residual
Table 5 Multivariable-adjusted* predictors of use of opioid pain medications after primary total knee arthroplasty
Multivariable-adjusted* analysis, 2-year follow-
up
Multivariable-adjusted* analysis, 5-year follow-
up
Odds ratio (95% CI) P-value Odds ratio (95% CI) P-value
Male gender (reference female) 0.54 (0.32, 0.92) 0.02a 0.39 (0.18, 0.84) 0.02a
Age (reference ≤ 60 yrs)
> 60 to 70 yrs 0.66 (0.36, 1.20) 0.17 0.80 (0.38, 1.70) 0.57
> 70 to 80 yrs 0.27 (0.13, 0.57) 0.001a 0.34 (0.14, 0.83) 0.02a
> 80 yrs 0.48 (0.19, 1.22) 0.12 0.39 (0.10, 1.57) 0.19
Body mass index (reference < 25 kg/m2)
25.0 to 29.9 1.00 (0.46, 2.17) 1.00 0.65 (0.24, 1.74) 0.39
30.0 to 34.9 1.10 (0.50, 2.44) 0.81 0.88 (0.31, 2.47) 0.80
35.0 to 39.9 1.25 (0.49, 3.22) 0.64 0.86 (0.29, 2.58) 0.79
≥ 40.0 0.54 (0.19, 1.59) 0.27 0.40 (0.10, 1.64) 0.20
Deyo-Charlson index (5-point change) 1.28 (0.70, 2.33) 0.43 1.03 (0.48, 2.21) 0.93
Depression (reference no depression) 1.05 (0.55, 2.00) 0.88 1.91 (0.83, 4.41) 0.13
Anxiety (reference no anxiety) 3.05 (1.62, 5.72) 0.001a 3.98 (1.68, 9.43) 0.002a
*Adjusted for American Society of Anesthesiologists (ASA) score, distance from the medical center, income, operative diagnosis and implant fixation in addition
to all the variables in the table; aSignificant odds ratios and P-values; CI, confidence interval. Goodness of fit statistic calculated as quasi likelihood ratio with
lower value indicating a better fit: 2 years, 824.3; 5 years, 519.1.
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confounding is possible. Currently there is no national
US joint registry, and therefore an analysis of data col-
lected over a considerable time period from a large
volume medical center (such as ours) is the next best
approach. We used the diagnostic codes for depression
and anxiety from medical records, and these are known
to be under-coded. A similar limitation applies to other
diagnoses in the Deyo-Charlson index. Such misclassifi-
cation bias would have made our estimates more conser-
vative compared to true associations. The actual
associations may have been even stronger, had all
patients been screened for depression using validated
instruments (Center for Epidemiological Studies Depres-
sion (CES-D) scale or Beck’s Depression Inventory), or
an examination by a psychologist. Despite a large sample
size, few patients reported use of opioid medication for
the index primary TKA pain, with approximately 10 to
15 patients per variable available for analysis in the multi-
variable-adjusted model. These results must not be over-
interpreted and need to be confirmed in future studies.
Non-responders to the survey may be more likely to have
poorer outcomes and a higher prevalence of use of pain
medication, therefore, the actual use of these medications
may be higher than that reported here. Our analyses did
not account for use of preoperative pain medication,
which might influence postoperative use.
Conclusions
In conclusion, using prospectively collected data from a
large US joint registry, we found that female gender and
younger age were associated with higher odds of use of
NSAIDs and opioid pain medication for the treatment of
residual pain in the index TKA, 2 and 5 years after pri-
mary TKA. Depression was associated with higher risk of
NSAID use and anxiety with higher risk of use of opioid
pain medication after primary TKA. Future studies
should examine whether pre- and postoperative optimi-
zation of treatment of depression and anxiety can reduce
the use of pain medication after primary TKA.
Additional material
Additional file 1: Non-responder characteristics. This file shows the
characteristics of non-responders from the primary total knee arthroplasty
(TKA) cohort at 2 and 5 years.
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